The prevalence of heart failure (HF) has markedly increased and now represents an enormous clinical and public health problem.
HF is a complex disorder involving different pathophysiological pathways with a wide range of possible underlying aetiologies and pathophysiological processes. Under this scenario the patient and process management around heart failure needs to be approached and aligned with personalised medicine as soon as possible.
With emerging insight into disease mechanisms and new treatment options, the time is now ripe for the cardiovascular field to adopt a more personalised approach to therapy and patient management. In this sense due to the complexity and diversity found in heart failure, and with the aim of treating and monitoring patients in the most personalised way, it is utmost importance to work on innovative technological solutions to enable effective patient-centred and patient-focused interventions.
To this end, it is essential to focus on innovative technologies that support and improve current CHF care pathway in order to provide much more personalised care.
In order to achieve this goal, we propose the use and incorporation of new holistic solution consisting of solutions that are already on the market or in prototype phase encompassed in Inno4HF platform to enable new heart failure patient personalised therapy strategies and effective patient-centred interventions.
The Inno4HF Platform proposed in the present project, will help us to transform the processes of value creation in heart failure patients, allowing an integrated care service model that improves the quality of life and outcomes.
This platform allows the architecture and structure to obtain an appropriate information exchange and to provide feedback among the different clinical levels to optimise the entire heart failure process of care, improve patient experience and outcomes and promote behavioural changes towards healthy life habits. The approach we are presenting will have a significant impact not only on patient quality of life, but also on optimising healthcare system resources.
